CDKL5 and epilepsy: A three-step epilepsy phenotype associated with CDKL5 variants has been described [72], consisting of early epilepsy (stage I), followed by epileptic encephalopathy (stage II), and finally late multifocal and myoclonic epilepsy (stage III).